Literature DB >> 21825067

Pseudomonas aeruginosa suppresses interferon response to rhinovirus infection in cystic fibrosis but not in normal bronchial epithelial cells.

Sangbrita S Chattoraj1, Shyamala Ganesan, Andrea Faris, Adam Comstock, Wai-Ming Lee, Umadevi S Sajjan.   

Abstract

Despite increased morbidity associated with secondary respiratory viral infections in cystic fibrosis (CF) patients with chronic Pseudomonas aeruginosa infection, the underlying mechanisms are not well understood. Here, we investigated the effect of P. aeruginosa infection on the innate immune responses of bronchial epithelial cells to rhinovirus (RV) infection. CF cells sequentially infected with mucoid P. aeruginosa (MPA) and RV showed lower levels of interferons (IFNs) and higher viral loads than those of RV-infected cells. Unlike results for CF cells, normal bronchial epithelial cells coinfected with MPA/RV showed higher IFN expression than RV-infected cells. In both CF and normal cells, the RV-stimulated IFN response requires phosphorylation of Akt and interferon response factor 3 (IRF3). Preinfection with MPA inhibited RV-stimulated Akt phosphorylation and decreased IRF3 phosphorylation in CF cells but not in normal cells. Compared to normal, unstimulated CF cells or normal cells treated with CFTR inhibitor showed increased reactive oxygen species (ROS) production. Treatment of CF cells with antioxidants prior to MPA infection partially reversed the suppressive effect of MPA on the RV-stimulated IFN response. Together, these results suggest that MPA preinfection inhibits viral clearance by suppressing the antiviral response particularly in CF cells but not in normal cells. Further, increased oxidative stress in CF cells appears to modulate the innate immune responses to coinfection.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21825067      PMCID: PMC3187241          DOI: 10.1128/IAI.05120-11

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  44 in total

1.  Cystic fibrosis and normal human airway epithelial cell response to influenza a viral infection.

Authors:  Weiling Xu; Shuo Zheng; Tannishia M Goggans; Patti Kiser; Miguel E Quinones-Mateu; Allison J Janocha; Suzy A A Comhair; Roger Slee; Bryan R G Williams; Serpil C Erzurum
Journal:  J Interferon Cytokine Res       Date:  2006-09       Impact factor: 2.607

Review 2.  COPD exacerbations . 2: aetiology.

Authors:  E Sapey; R A Stockley
Journal:  Thorax       Date:  2006-03       Impact factor: 9.139

3.  Synthetic double-stranded RNA induces multiple genes related to inflammation through Toll-like receptor 3 depending on NF-kappaB and/or IRF-3 in airway epithelial cells.

Authors:  S Matsukura; F Kokubu; M Kurokawa; M Kawaguchi; K Ieki; H Kuga; M Odaka; S Suzuki; S Watanabe; H Takeuchi; T Kasama; M Adachi
Journal:  Clin Exp Allergy       Date:  2006-08       Impact factor: 5.018

4.  H. influenzae potentiates airway epithelial cell responses to rhinovirus by increasing ICAM-1 and TLR3 expression.

Authors:  Umadevi S Sajjan; Yue Jia; Dawn C Newcomb; J Kelley Bentley; Nicholas W Lukacs; John J LiPuma; Marc B Hershenson
Journal:  FASEB J       Date:  2006-08-16       Impact factor: 5.191

5.  MPB-07 reduces the inflammatory response to Pseudomonas aeruginosa in cystic fibrosis bronchial cells.

Authors:  Maria Cristina Dechecchi; Elena Nicolis; Valentino Bezzerri; Antonio Vella; Marco Colombatti; Baroukh Maurice Assael; Yvette Mettey; Monica Borgatti; Irene Mancini; Roberto Gambari; Frederic Becq; Giulio Cabrini
Journal:  Am J Respir Cell Mol Biol       Date:  2006-12-29       Impact factor: 6.914

6.  Novel mouse model of chronic Pseudomonas aeruginosa lung infection mimicking cystic fibrosis.

Authors:  Nadine Hoffmann; Thomas Bovbjerg Rasmussen; Peter Østrup Jensen; Charlotte Stub; Morten Hentzer; Søren Molin; Oana Ciofu; Michael Givskov; Helle Krogh Johansen; Niels Høiby
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

7.  Phosphatidylinositol 3-kinase is required for rhinovirus-induced airway epithelial cell interleukin-8 expression.

Authors:  Dawn C Newcomb; Uma Sajjan; Suparna Nanua; Yue Jia; Adam M Goldsmith; J Kelley Bentley; Marc B Hershenson
Journal:  J Biol Chem       Date:  2005-08-24       Impact factor: 5.157

8.  Ten years of viral and non-bacterial serology in adults with cystic fibrosis.

Authors:  I J Clifton; J A Kastelik; D G Peckham; A Hale; M Denton; C Etherington; S P Conway
Journal:  Epidemiol Infect       Date:  2007-03-12       Impact factor: 2.451

9.  Cooperative effects of rhinovirus and TNF-{alpha} on airway epithelial cell chemokine expression.

Authors:  Dawn C Newcomb; Umadevi S Sajjan; Deepti R Nagarkar; Adam M Goldsmith; J Kelley Bentley; Marc B Hershenson
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2007-07-13       Impact factor: 5.464

10.  Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus.

Authors:  Peter A B Wark; Sebastian L Johnston; Fabio Bucchieri; Robert Powell; Sarah Puddicombe; Vasile Laza-Stanca; Stephen T Holgate; Donna E Davies
Journal:  J Exp Med       Date:  2005-03-21       Impact factor: 14.307

View more
  29 in total

1.  Differential responses to rhinovirus- and influenza-associated pulmonary exacerbations in patients with cystic fibrosis.

Authors:  Ixsy A Ramirez; Lindsay J Caverly; Lindsay L Caverly; Linda M Kalikin; Adam M Goldsmith; Toby C Lewis; David T Burke; John J LiPuma; Uma S Sajjan; Marc B Hershenson
Journal:  Ann Am Thorac Soc       Date:  2014-05

2.  Respiratory syncytial virus infection enhances Pseudomonas aeruginosa biofilm growth through dysregulation of nutritional immunity.

Authors:  Matthew R Hendricks; Lauren P Lashua; Douglas K Fischer; Becca A Flitter; Katherine M Eichinger; Joan E Durbin; Saumendra N Sarkar; Carolyn B Coyne; Kerry M Empey; Jennifer M Bomberger
Journal:  Proc Natl Acad Sci U S A       Date:  2016-01-04       Impact factor: 11.205

Review 3.  Human rhinoviruses.

Authors:  Samantha E Jacobs; Daryl M Lamson; Kirsten St George; Thomas J Walsh
Journal:  Clin Microbiol Rev       Date:  2013-01       Impact factor: 26.132

4.  IFNβ/TNFα synergism induces a non-canonical STAT2/IRF9-dependent pathway triggering a novel DUOX2 NADPH oxidase-mediated airway antiviral response.

Authors:  Karin Fink; Lydie Martin; Esperance Mukawera; Stéfany Chartier; Xavier De Deken; Emmanuelle Brochiero; Françoise Miot; Nathalie Grandvaux
Journal:  Cell Res       Date:  2013-04-02       Impact factor: 25.617

Review 5.  Digging through the Obstruction: Insight into the Epithelial Cell Response to Respiratory Virus Infection in Patients with Cystic Fibrosis.

Authors:  Matthew R Hendricks; Jennifer M Bomberger
Journal:  J Virol       Date:  2016-04-14       Impact factor: 5.103

Review 6.  The emerging relationship between the airway microbiota and chronic respiratory disease: clinical implications.

Authors:  Yvonne J Huang; Susan V Lynch
Journal:  Expert Rev Respir Med       Date:  2011-12       Impact factor: 3.772

7.  Rhinovirus-Induced SIRT-1 via TLR2 Regulates Subsequent Type I and Type III IFN Responses in Airway Epithelial Cells.

Authors:  Nathaniel Xander; Hymavathi Reddy Vari; Rewees Eskandar; Wuyan Li; Sudhir Bolla; Nathaniel Marchetti; Umadevi S Sajjan
Journal:  J Immunol       Date:  2019-09-23       Impact factor: 5.422

8.  TLR2 Activation Limits Rhinovirus-Stimulated CXCL-10 by Attenuating IRAK-1-Dependent IL-33 Receptor Signaling in Human Bronchial Epithelial Cells.

Authors:  Shyamala Ganesan; Duc Pham; Yaxun Jing; Mohammad Farazuddin; Magdalena H Hudy; Benjamin Unger; Adam T Comstock; David Proud; Adam S Lauring; Uma S Sajjan
Journal:  J Immunol       Date:  2016-08-08       Impact factor: 5.422

9.  Chronic rhinovirus infection in an adult with cystic fibrosis.

Authors:  William G Flight; Rowland J Bright-Thomas; Peter Tilston; Kenneth J Mutton; Malcolm Guiver; A Kevin Webb; Andrew M Jones
Journal:  J Clin Microbiol       Date:  2013-08-21       Impact factor: 5.948

10.  Exploring the therapeutic potential of forkhead box O for outfoxing COVID-19.

Authors:  Pradeep Singh Cheema; Deeptashree Nandi; Alo Nag
Journal:  Open Biol       Date:  2021-06-09       Impact factor: 6.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.